首页> 外文期刊>Allergy, Asthma & Immunology Research >Plasma Levels of Matrix Metalloproteinase-9 in Children With Chronic Spontaneous Urticaria
【24h】

Plasma Levels of Matrix Metalloproteinase-9 in Children With Chronic Spontaneous Urticaria

机译:慢性自发性荨麻疹患儿血浆MMP-9的水平

获取原文
获取外文期刊封面目录资料

摘要

Purpose Chronic spontaneous urticaria (CSU) is a disease that is primarily seen in adults and is comparatively rare in children. Consequently, only a few studies have focused on the pathogenesis of the disease in children. This study investigated the possible role of metalloproteinase-9 (MMP-9) in the pathogenesis of CSU in children. Methods The study group was composed of 54 children with CSU; 34 healthy children comprised the control group. The demographic and clinical features of the study group were extensively evaluated, and laboratory assessments were also performed. An enzyme-linked immunosorbent assay was used to evaluate levels of plasma MMP-9. Disease activity was quantified using the urticaria activity score (UAS). Results The median value of plasma MMP-9 was 108.9 ng/mL (interquartile range, 93.3-124.1) in the CSU group and 87.8 ng/mL (69.4-103.0) in the control group. The difference between the 2 groups was statistically significant ( P 0.05). Conclusions Plasma MMP-9 levels were elevated in children with CSU and were positively correlated with disease activity. MMP-9 may be both a good biomarker of disease activity and a potential therapeutic target in CSU.
机译:目的慢性自发性荨麻疹(CSU)是一种主要见于成人的疾病,在儿童中相对较少。因此,只有很少的研究集中在儿童疾病的发病机理上。这项研究调查了金属蛋白酶9(MMP-9)在儿童CSU发病中的可能作用。方法研究组由54名CSU患儿组成。对照组为34名健康儿童。对研究组的人口统计学和临床​​特征进行了广泛评估,并进行了实验室评估。酶联免疫吸附测定法用于评估血浆MMP-9的水平。使用荨麻疹活性评分(UAS)量化疾病活性。结果CSU组血浆MMP-9的中位数为108.9 ng / mL(四分位数范围,93.3-124.1),对照组为87.8 ng / mL(69.4-103.0)。两组之间的差异具有统计学意义(P 0.05)。结论CSU患儿血浆MMP-9水平升高,与疾病活动度呈正相关。 MMP-9可能既是疾病活动的良好生物标志物,又是CSU中潜在的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号